13F HOLDINGS REPORT
Caligan Partners LP
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001420506-25-002188
Total Value
$520.2M
Positions
17
Other Managers
0
Confidential Omitted
No
Holdings (17)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VERONA PHARMA PLC | 925050106 | 1,436,878 | $135.9M | 26.13% |
| 2 | LIQUIDIA CORPORATION | LQDA | 8,118,892 | $101.2M | 19.45% |
| 3 | EXELIXIS INC | EXEL | 1,525,730 | $67.2M | 12.93% |
| 4 | AGIOS PHARMACEUTICALS INC | AGIO | 1,071,258 | $35.6M | 6.85% |
| 5 | MERUS N V | N5749R100 | 656,999 | $34.6M | 6.64% |
| 6 | EVOLUS INC | EOLS | 3,341,970 | $30.8M | 5.92% |
| 7 | MINERALYS THERAPEUTICS INC | MLYS | 2,017,352 | $27.3M | 5.25% |
| 8 | REVOLUTION MEDICINES INC | RVMDW | 636,835 | $23.4M | 4.50% |
| 9 | ANIKA THERAPEUTICS INC | ANIK | 1,435,130 | $15.2M | 2.92% |
| 10 | ABIVAX SA | AAVXF | 1,674,400 | $12.8M | 2.46% |
| 11 | Y-MABS THERAPEUTICS INC | 984241109 | 2,342,609 | $10.6M | 2.03% |
| 12 | REZOLUTE INC | RZLT | 1,543,014 | $6.9M | 1.32% |
| 13 | BIOCRYST PHARMACEUTICALS INC | BCRX | 638,908 | $5.7M | 1.10% |
| 14 | SELLAS LIFE SCIENCES GROUP I | SLS | 2,300,000 | $5.0M | 0.97% |
| 15 | VERRICA PHARMACEUTICALS INC | VRCA | 9,239,119 | $4.9M | 0.94% |
| 16 | TYRA BIOSCIENCES INC | TYRA | 189,950 | $1.8M | 0.35% |
| 17 | AURA BIOSCIENCES INC | AURA | 200,000 | $1.3M | 0.24% |